Bank of Montreal Can raised its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 210,450 shares of the technology company's stock after buying an additional 4,569 shares during the quarter. Bank of Montreal Can owned about 0.19% of Amdocs worth $17,918,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of DOX. Jones Financial Companies Lllp bought a new stake in Amdocs during the fourth quarter worth about $36,000. SBI Securities Co. Ltd. bought a new stake in Amdocs in the fourth quarter worth $41,000. Global Retirement Partners LLC raised its position in shares of Amdocs by 45.6% in the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock worth $48,000 after purchasing an additional 175 shares during the last quarter. Private Trust Co. NA increased its stake in Amdocs by 121.5% during the 4th quarter. Private Trust Co. NA now owns 671 shares of the technology company's stock valued at $57,000 after purchasing an additional 368 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Amdocs by 199.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 686 shares of the technology company's stock worth $59,000 after buying an additional 457 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Stock Performance
NASDAQ DOX traded down $0.18 on Thursday, reaching $83.10. 148,203 shares of the stock were exchanged, compared to its average volume of 699,321. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. Amdocs Limited has a one year low of $74.41 and a one year high of $93.34. The company's 50-day simple moving average is $87.51 and its two-hundred day simple moving average is $87.19. The firm has a market capitalization of $9.38 billion, a PE ratio of 19.26, a PEG ratio of 1.47 and a beta of 0.59.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a dividend of $0.527 per share. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.54%. Amdocs's dividend payout ratio is presently 48.72%.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, Amdocs has an average rating of "Moderate Buy" and an average target price of $101.20.
View Our Latest Report on Amdocs
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.